RISKREVEAL Trademark

Trademark Overview


On Monday, December 4, 2023, a trademark application was filed for RISKREVEAL with the United States Patent and Trademark Office. The USPTO has given the RISKREVEAL trademark a serial number of 98297986. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, January 7, 2025. This trademark is owned by Razor Genomics, Inc.. The RISKREVEAL trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical molecular diagnostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical prognostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical molecular prognostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical diagnostic molecular treatment stratification test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical prognostic molecular treatment stratification test kits comprised of primers and probes for quantitative polymer...
riskreveal

General Information


Serial Number98297986
Word MarkRISKREVEAL
Filing DateMonday, December 4, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, January 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements


Goods and ServicesMedical diagnostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical molecular diagnostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical prognostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical molecular prognostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical diagnostic molecular treatment stratification test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical prognostic molecular treatment stratification test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Formalin fixed, paraffin embedded (FFPE) diagnostic kits comprised of medical diagnostic reagents and assays for testing of tumor tissue for use in risk segregation and managing disease treatment, namely, cancer
Pseudo MarkRISK REVEAL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRazor Genomics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Party NameRazor Genomics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events


Event DateEvent Description
Thursday, December 7, 2023NEW APPLICATION ENTERED
Wednesday, January 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 1, 2024ASSIGNED TO EXAMINER
Tuesday, July 9, 2024NON-FINAL ACTION E-MAILED
Tuesday, July 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 9, 2024NON-FINAL ACTION WRITTEN
Thursday, October 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 31, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, October 31, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, October 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 31, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, October 31, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT